Genmab A/S (GMAB)

Genmab Income Statement

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Revenue	3,647	2,988	2,443	2,084	1,287	1,662
Revenue Growth (YoY)	32.97%	22.32%	17.23%	61.88%	-22.52%	106.20%
Cost of Revenue	199.07	136.74	33.52	-	-	-
Gross Profit	3,448	2,852	2,410	2,084	1,287	1,662
Selling, General & Admin	623.67	526.14	488.94	384.48	196.24	108.63
Research & Development	1,550	1,343	1,132	799.14	639.51	515.54
Operating Expenses	2,173	1,869	1,620	1,184	835.75	624.17
Operating Income	1,274	982.72	789.09	900.43	451.68	1,037
Interest Expense	-25.89	-16.66	-10.38	-5.6	-1.99	-1.64
Interest & Investment Income	126.64	138.13	145.63	46.55	30.13	30.24
Currency Exchange Gain (Loss)	179.8	185.88	-131.84	151.01	224.85	-239.28
EBT Excluding Unusual Items	1,555	1,290	792.5	1,092	704.67	826.8
Merger & Restructuring Charges	-11.23	-41.65	-	-	-	-
Gain (Loss) on Sale of Investments	21.89	34.29	43.45	-94.54	-105.39	143.47
Asset Writedown	-11.96	-10.55	-	-	-	-
Pretax Income	1,554	1,272	835.95	997.85	599.28	970.27
Income Tax Expense	182.81	183.25	190.56	214.51	146.99	188.34
Net Income	1,371	1,089	645.39	783.33	452.29	781.94
Net Income to Common	1,371	1,089	645.39	783.33	452.29	781.94
Net Income Growth	71.73%	68.72%	-17.61%	73.19%	-42.16%	140.38%
Shares Outstanding (Basic)	63	64	65	65	65	65
Shares Outstanding (Diluted)	63	65	66	66	66	66
Shares Change (YoY)	-3.37%	-1.94%	-0.14%	-0.06%	0.24%	3.53%
EPS (Basic)	21.72	16.96	9.88	11.98	6.92	12.00
EPS (Diluted)	21.62	16.85	9.79	11.87	6.85	11.87
EPS Growth	77.72%	72.08%	-17.49%	73.29%	-42.30%	132.20%
Free Cash Flow	1,091	1,053	1,040	516.52	302.24	1,007
Free Cash Flow Per Share	17.20	16.29	15.78	7.83	4.58	15.28
Gross Margin	94.54%	95.42%	98.63%	100.00%	100.00%	100.00%
Operating Margin	34.95%	32.89%	32.30%	43.21%	35.08%	62.44%
Profit Margin	37.59%	36.44%	26.42%	37.59%	35.13%	47.06%
Free Cash Flow Margin	29.92%	35.23%	42.58%	24.79%	23.48%	60.59%
EBITDA	1,327	1,026	819.93	941.81	481.35	1,075
EBITDA Margin	36.40%	34.33%	33.56%	45.19%	37.39%	64.71%
D&A For EBITDA	52.96	43.17	30.85	41.38	29.67	37.8
EBIT	1,274	982.72	789.09	900.43	451.68	1,037
EBIT Margin	34.95%	32.89%	32.30%	43.21%	35.08%	62.44%
Effective Tax Rate	11.77%	14.40%	22.80%	21.50%	24.53%	19.41%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q